For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Scope of the Report:
This report focuses on the Cyazofamid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
4-methylacetophenone is the main raw materials. Cyazofamid are often applied to treat downy mildew oomycetes diseases.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, which production reached 335 MT in 2016, with the share of 81.91%.
The consumption shares of Japan, China, North America and Europe were 42.79%, 21.52%, 17.11% and 11.74%. Japan is the main import region and other countries need to import from Japan.
The worldwide market for Cyazofamid is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 90 million US$ in 2023, from 82 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- ISHIHARA SANGYO KAISHA
- Rudong Zhongyi
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Type I
- Type II
Market Segment by Applications, can be divided into
- Downy Mildew
- Oomycetes Diseases
There are 15 Chapters to deeply display the global Cyazofamid market.
Chapter 1, to describe Cyazofamid Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cyazofamid, with sales, revenue, and price of Cyazofamid, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cyazofamid, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cyazofamid market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cyazofamid sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source